amit@unlistedkraft.in
+91-9599071664
+91-9599071664
Lords Mark Industries Pvt Ltd Unlisted Shares
DRHP Status : DHRP not filed
80
Fundamentals About Lords Mark Industries Pvt Ltd
Downloads & Investor Documents
All documents are provided for informational purposes and are subject to regulatory disclosures.
Key Financials of Lords Mark Industries Pvt Ltd
| P&L Statement | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 213 | 305 | 555 |
| Cost of Material Consumed | 194 | 270 | 481 |
| Gross Margins | 8.92 | 11.48 | 13.33 |
| Change in Inventory | 0 | 0 | 0 |
| Employee Benefit Expenses | 1.8 | 6.6 | 17 |
| Other Expenses | 4.1 | 6.2 | 19 |
| EBITDA | 13.1 | 22.2 | 38 |
| OPM | 6.15 | 7.28 | 6.85 |
| Other Income | 0.9 | 0.8 | 1.5 |
| Finance Cost | 6 | 11.5 | 18.2 |
| D&A | 2.1 | 4.6 | 5 |
| EBIT | 11 | 17.6 | 33 |
| EBIT Margins | 5.16 | 5.77 | 5.95 |
| PBT | 5.5 | 6.4 | 15.5 |
| PBT Margins | 2.58 | 2.1 | 2.79 |
| Tax | 1.3 | 1.8 | 4.2 |
| PAT | 4.2 | 4.6 | 11.3 |
| NPM | 1.97 | 1.51 | 2.04 |
| EPS | 4.2 | 0.82 | 1.01 |
Financial Ratios |
2022 | 2023 | 2024 |
|---|---|---|---|
| Operating Profit Margin | 6.15 | 7.28 | 6.85 |
| Net Profit Margin | 1.97 | 1.51 | 2.04 |
| Earning Per Share (Diluted) | 4.2 | 0.82 | 1.01 |
| Assets | 2022 | 2023 | 2024 |
|---|---|---|---|
| Fixed Assets | 18.8 | 35 | 47 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Trade Receivables | 112 | 84.7 | 159 |
| Inventory | 67.8 | 91.4 | 99 |
| Other Assets | 21.6 | 29.4 | 52 |
| Total Assets | 220.2 | 240.5 | 357 |
About Company
Let us take a glance at key points about the Lords Mark Industries Pvt. Ltd. After the following table, we will explain these points in detail:
| Parameter | Key Numbers | Insights |
|---|---|---|
| Business Overview | Founded in 1998; diversified across healthcare diagnostics, MedTech, renewable energy, and printing/packaging | Multi-vertical conglomerate transitioning toward high-growth healthcare and sustainable technology sectors. |
| Industry & Market Position | 300+ products including MedTech & diagnostics; US FDA listings for 153 orthosurgical products | Growing med-tech presence supported by global regulatory certifications. |
| Revenue Growth Trend | Revenue ₹213 Cr (FY22) → ₹555 Cr (FY24); ~28% CAGR (FY22–FY24) | Strong top-line growth driven by expanding product portfolio and geographic reach. |
| Profitability & Margins | PAT ₹4.2 Cr (FY22) → ₹11.3 Cr (FY24); Net margin ~2.04% (FY24) | Bottom-line improving with gradual margin expansion as scale increases. |
| Cash Flow Quality | Operating activities and investing spends reported; detailed cash flow data not fully public | Cash flows impacted by expansion-related capex and working capital requirements. |
| Balance Sheet Strength | Total assets ₹220 Cr → ₹357 Cr (FY22–FY24); borrowings increased alongside equity infusion | Balance sheet expanding with asset growth, though leverage has risen due to growth financing. |
| Unlisted Valuation | ~₹2,887 Crore | Valuation reflects high-growth healthcare potential, FDA approvals, and listing expectations. |
| Management & Governance | MD & CEO: Dr. Sachidanand Upadhyay; diversified industry leadership | Professional management focused on global expansion and product innovation. |
| Growth Triggers & Catalysts | US FDA approvals, NABL accreditation, Renalyx acquisition, and BSE listing plans | Multiple catalysts across approvals, diagnostics growth, and public listing pathways. |
| Liquidity & Exit Visibility | Operating and investing activity ongoing; pre-listing phase | Liquidity limited until listing; exit expected via public market listing. |
Lord’s Mark Industries (sometimes “LordsMark”) is a diversified Indian conglomerate with major verticals in Diagnostics & MedTech, Renewable Energy (LED / Solar), and Specialty Paper. Its diagnostics division, called LordsMed, manufactures in-vitro diagnostic (IVD) kits (rapid test kits, biochemistry reagents), semi-auto analyzers, and more. The following are its main arms:
- In renewable energy/lighting: operates under brands like Pavak (LED) and Lords Turbo (solar inverters).
- Paper business: manufactures computer continuous paper stationery and specialty paper.
- Other group/sister companies include: Lords Mark Biotech, Lords Mark Microbiotech, Lords Automotive, Lords Mark Insurance, etc.
History & Leadership
- Founded in 1998.
- Sachidanand Upadhyay is the Managing Director & CEO.
- On its website, it describes a 25+ year journey and a “Growth Decade” ahead
Certifications & Quality
- IVD / MedTech business has ISO 13485 certification (medical devices quality standard).
- According to its catalogue, it produces over 45 biochemistry reagents and various rapid test kits.
Recent News & Strategic Highlights
- Lord’s Mark completed its first USD 1 million MedTech export to the U.S. recently.
- It secured US FDA registration for surgical consumables, orthopedic supports, and hygiene products — a big milestone for global healthcare manufacturing.
- The company is planning to list on the Bombay Stock Exchange (BSE), with possible future entry on the NSE.
- Under its LED / solar business, it won a contract for solar street lighting in Ayodhya.
- It has a strong export ambition in diagnostics: targeting 6.55 million IVD supplies to SAARC countries.
Strengths & Growth Drivers
- Diversified Conglomerate: Having business in diagnostics, renewable energy, and paper mitigates risk and captures growth in multiple sectors.
- Export & Global Ambition: Diagnostics export to SAARC + U.S. FDA registration shows global intent.
- Innovation in Healthcare: Investment in IVD, bio-reagents, and smart diagnostic solutions (e.g., portable / E-Smart clinics)
- Renewable Focus: Solar and LED vertical aligns with India’s energy transition.
- Strong Leadership: MD & CEO with clarity on long-term growth; diversified board.
- Scaling Assets: With strengthening manufacturing (IVD) + energy projects, potential for asset-based growth.
Risks & Challenges
- Capital Intensity: Diagnostics manufacturing + solar projects require heavy capex.
- Regulatory Risk: Medical diagnostics is heavily regulated; quality and regulatory approvals are critical.
- Competition: Strong competition both in IVD (global + domestic) and solar / LED.
- Execution Risk: Ambitious expansion (exports, listings) may strain financials if not executed well.
- Unlisted Liquidity Risk: As an unlisted share, liquidity for investors may be limited, and exit might be difficult.
- Legacy Business Pressure: Its paper business might drag if not divested efficiently
Quick Summary
Lord’s Mark Industries Ltd is a fast-growing, diversified conglomerate positioned at the intersection of healthcare diagnostics and renewable energy. With strong leadership, regulatory certifications, and export ambitions, it’s well-placed for long-term growth. For unlisted-share investors, it’s a compelling play — but one that comes with notable execution and capital risk. If the company successfully lists, that could be a major value unlock.
Click here to visit the official website of Lords Mark Industries Pvt Ltd.
Shareholding Pattern of Lords Mark Industries Pvt Ltd
| Name | Holding |
|---|---|
| Promoters | 94.86% |
| Public | 5.14% |
Promoters of Lords Mark Industries Pvt Ltd
| Name | Designation | Linkedin Profile/Notes |
|---|---|---|
| Sachidanand Upadhyay | MD & CEO | No confirmed public LinkedIn profile found. |
| Manav Teli | Executive Director | Mentioned in company profile. |
Latest News
Latest Post
Coming soon...
Coming soon...
Frequently Asked Questions
Lords Mark Industries Pvt Ltd unlisted shares refer to equity in a privately held chemicals and speciality materials manufacturer that is not listed on NSE or BSE. These shares are traded privately through platforms like UnlistedKraft.
Yes, UnlistedKraft offers verified access to Lords Mark Industries Pvt Ltd unlisted shares. After completing your KYC and placing an order, the shares are typically credited to your demat account within 24 hours.
Unlisted shares involve risks such as lower liquidity and limited public disclosure. However, Lords Mark Industries is known for its speciality chemical products, and investing via UnlistedKraft ensures your transaction is secure, verified, and transparent.
The share price depends on recent private trades, company financial performance, market demand, and valuation trends. UnlistedKraft updates pricing regularly to reflect fair and transparent valuation.
Yes, an active demat account is required to receive and hold unlisted shares such as those of Lords Mark Industries Pvt Ltd.
There is no mandatory holding period unless the company lists on a public exchange. Most investors hold these shares until a liquidity event such as an IPO or acquisition for long-term potential gains.
Yes, you can resell your shares before an IPO via UnlistedKraft’s resale network, depending on buyer demand and prevailing market conditions.
Yes. Under SEBI regulations, pre-IPO investors must observe a six-month lock-in period after the shares are listed publicly.
If held for more than two years, gains are considered long-term capital gains and taxed at 20 percent with indexation. If sold within two years, gains are treated as short-term and taxed according to your applicable income tax slab.
UnlistedKraft provides verified investment access to unlisted opportunities like Lords Mark Industries Pvt Ltd, with transparent pricing, expert support, secure transactions, and fast share credit to your demat account, making it a trusted platform for private-market investing.
+91-9599071664
amit@unlistedkraft.in